[go: up one dir, main page]

CL2007003838A1 - Composiciones farmaceuticas que contienen compuestos semisinteticos derivados de los alcaloides de la vinca, utiles para tratar el cancer. - Google Patents

Composiciones farmaceuticas que contienen compuestos semisinteticos derivados de los alcaloides de la vinca, utiles para tratar el cancer.

Info

Publication number
CL2007003838A1
CL2007003838A1 CL200703838A CL2007003838A CL2007003838A1 CL 2007003838 A1 CL2007003838 A1 CL 2007003838A1 CL 200703838 A CL200703838 A CL 200703838A CL 2007003838 A CL2007003838 A CL 2007003838A CL 2007003838 A1 CL2007003838 A1 CL 2007003838A1
Authority
CL
Chile
Prior art keywords
semisintetic
useful
pharmaceutical compositions
compositions containing
treat cancer
Prior art date
Application number
CL200703838A
Other languages
English (en)
Inventor
Elle Bougaret Joel Ibar Leverd
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38293420&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2007003838(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of CL2007003838A1 publication Critical patent/CL2007003838A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
CL200703838A 2006-12-29 2007-12-27 Composiciones farmaceuticas que contienen compuestos semisinteticos derivados de los alcaloides de la vinca, utiles para tratar el cancer. CL2007003838A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0656044A FR2910812B1 (fr) 2006-12-29 2006-12-29 Compositions pharmaceutiques injectables lyophilisees de derives hemi-synthetiques d'alcaloide de vinca stables a temperature ambiante
US89705907P 2007-01-24 2007-01-24

Publications (1)

Publication Number Publication Date
CL2007003838A1 true CL2007003838A1 (es) 2008-07-04

Family

ID=38293420

Family Applications (1)

Application Number Title Priority Date Filing Date
CL200703838A CL2007003838A1 (es) 2006-12-29 2007-12-27 Composiciones farmaceuticas que contienen compuestos semisinteticos derivados de los alcaloides de la vinca, utiles para tratar el cancer.

Country Status (23)

Country Link
US (1) US8304424B2 (es)
EP (1) EP2120934B1 (es)
JP (1) JP2010514737A (es)
KR (1) KR20090097883A (es)
CN (1) CN101534821B (es)
AR (1) AR064715A1 (es)
AU (1) AU2007341231B2 (es)
BR (1) BRPI0722076A2 (es)
CA (1) CA2673232A1 (es)
CL (1) CL2007003838A1 (es)
FR (1) FR2910812B1 (es)
IL (1) IL199556A (es)
MA (1) MA30892B1 (es)
MX (1) MX2009006949A (es)
NO (1) NO20092726L (es)
NZ (1) NZ576583A (es)
RU (1) RU2449791C2 (es)
SA (1) SA07280720B1 (es)
TN (1) TN2009000258A1 (es)
TW (1) TWI415631B (es)
UA (1) UA96977C2 (es)
WO (1) WO2008080968A1 (es)
ZA (1) ZA200903115B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102151249A (zh) * 2010-02-11 2011-08-17 石药集团中奇制药技术（石家庄）有限公司 一种长春氟宁的药用组合物
JO3112B1 (ar) * 2010-03-29 2017-09-20 Ferring Bv تركيبة دوائية سريعة التحلل
CN102772373B (zh) * 2011-05-11 2015-09-02 石药集团中奇制药技术（石家庄）有限公司 一种注射用酒石酸长春瑞滨粉针剂及其制备方法
CN118286868A (zh) 2018-08-31 2024-07-05 富士胶片欧文科技有限公司 用于混合设备的排气系统

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1170152B (it) * 1982-07-19 1987-06-03 Lilly Co Eli Miglioramenti a o riguardanti formulazioni di vinca-alcaloidi
US4619935A (en) * 1983-03-17 1986-10-28 Eli Lilly And Company Stable oncolytic formulations
US4923876A (en) * 1988-04-18 1990-05-08 Cetus Corporation Vinca alkaloid pharmaceutical compositions
HUT54308A (en) * 1989-04-04 1991-02-28 Lilly Co Eli Process for producing immunoglobulin conjugates and medicaments comprising same
US6143276A (en) * 1997-03-21 2000-11-07 Imarx Pharmaceutical Corp. Methods for delivering bioactive agents to regions of elevated temperatures
FR2761990B1 (fr) * 1997-04-10 1999-06-25 Pf Medicament Derives halogenes antimitotiques d'alcaloides de vinca
NZ534378A (en) * 2002-02-22 2006-10-27 Schering Corp Pharmaceutical formulations of antineoplastic agents, in particular temozolomide, processes of making and using the same
FR2863891B1 (fr) * 2003-12-23 2006-03-24 Pf Medicament Composition pharmaceutique de vinflunine destinee a une administration parentale, procede de preparation et utilisation
ES2967961T3 (es) * 2004-05-03 2024-05-06 Ipsen Biopharm Ltd Liposomas útiles en la administración de fármacos
PE20061107A1 (es) * 2005-03-14 2006-12-08 Wyeth Corp Composiciones de tigeciclina y metodos para su preparacion

Also Published As

Publication number Publication date
FR2910812B1 (fr) 2009-03-20
US8304424B2 (en) 2012-11-06
MX2009006949A (es) 2009-07-14
NO20092726L (no) 2009-07-20
JP2010514737A (ja) 2010-05-06
AU2007341231A1 (en) 2008-07-10
AR064715A1 (es) 2009-04-22
TN2009000258A1 (en) 2010-10-18
RU2449791C2 (ru) 2012-05-10
IL199556A (en) 2014-09-30
AU2007341231B2 (en) 2013-03-21
ZA200903115B (en) 2010-04-28
TWI415631B (zh) 2013-11-21
CN101534821B (zh) 2012-01-25
WO2008080968A1 (en) 2008-07-10
KR20090097883A (ko) 2009-09-16
MA30892B1 (fr) 2009-11-02
SA07280720B1 (ar) 2012-02-07
FR2910812A1 (fr) 2008-07-04
BRPI0722076A2 (pt) 2014-04-08
US20100087473A1 (en) 2010-04-08
UA96977C2 (ru) 2011-12-26
NZ576583A (en) 2012-01-12
EP2120934A1 (en) 2009-11-25
TW200833369A (en) 2008-08-16
HK1130439A1 (en) 2009-12-31
CA2673232A1 (en) 2008-07-10
RU2009128327A (ru) 2011-02-10
CN101534821A (zh) 2009-09-16
EP2120934B1 (en) 2014-05-07

Similar Documents

Publication Publication Date Title
CL2007003138A1 (es) Compuestos derivados de anilinopiperazina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer.
CL2007003226A1 (es) Compuestos derivados de piridinona; composicion farmaceutica; y uso para tratar el cancer.
CL2008000789A1 (es) Compuestos derivados de adenina; composicion farmaceutica que comprende a dichos compuestos, utiles para tratar enfermedades alergicas, virales o cancer, entre otras.
CL2007003758A1 (es) Compuestos derivados de aminopirimidina, inhibidores de plk1; composicion farmaceutica, util para el tratamiento de cancer.
CR20140544A (es) Compuestos para inhibir la progresión mitotica
BRPI0819218A2 (pt) Métodos, estojos e composições para administração de compostos farmacêuticos
GT200900027A (es) Compuestos organicos
CL2007002682A1 (es) Compuestos derivados de 4-metilpiridopirimidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar el crecimiento anormal de celulas, como cancer.
CL2011000134A1 (es) Compuestos derivados de aminofenoxiindazoles, inhibidores de c-met; composicion farmaceutica que comprende a estos compuestos; y su uso para tratar el cancer.
CL2008002319A1 (es) Compuestos derivados de pirrolopirimidina; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar cancer.
CL2008000754A1 (es) Compuesto derivado de heterociclos de nitrogeno; composicion farmaceutica que comprende a dicho compuesto; y uso para tratar cancer y trastornos hiperproliferativos.
EA201170772A1 (ru) Органические соединения
CL2012003415A1 (es) Compuestos derivados de 2-oxo-piperidina y 1,1-dioxido-tiazina, inhibidores de mdm2; composicion farmaceutica que los comprende; y su uso para el tratamiento del cancer .
CL2008000029A1 (es) Compuestos derivados de 1-bencil imidazol, inhibidores de eg-5; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar cancer.
CL2007002424A1 (es) Compuestos derivados de isoxazolidina; composicion farmaceutica que comprende a dicho compuesto, util para el tratamiento de trastornos asociados con hiperproliferacion como cancer.
CL2007003202A1 (es) Compuestos derivados de espiroindolinona; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de trastornos de proliferacion celular.
CL2007003049A1 (es) Compuestos derivados de 2,4-diaminopirimidina; composicion farmaceutica, utiles para tratar trastornos proliferativos.
CL2008000197A1 (es) Compuestos derivados de 2,4-diamino pirimidina, inhibidores de antranilamida de cinasa aurora; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar cancer.
GT201000376A (es) Compuestos organicos
CL2007003212A1 (es) Compuestos derivados de imidazopirazinas, inhibidores de proteina quinasa; composicion farmaceutica que los comprende; y su uso para tratar cancer.
CL2011000191A1 (es) Compuestos derivados de pirimidina fusionada sustituida,inhibidores de mtor; composicion farmaceutica que lo comprende; y uso en el tratamiento del cancer.
CL2007001995A1 (es) Compuestos derivados de pirrolotriazina; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar el cancer.
ECSP088676A (es) Pirazolquinolonas como potentes inhibidores de parp
CL2008002430A1 (es) Compuestos derivados de bencenosulfonamida, inhibidores de catepsina c; composicion farmaceutica que los comprende; y su uso para el tratamiento de la epoc.
UY30220A1 (es) Compuestos de tetrahidropiridotienopirimidina y metodos para su empleo